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Most biomolecular interactions are typically thought to increase the (local)
rigidity of a complex, for example, in drug-target binding. However,
detailed analysis of specific biomolecular complexes can reveal a more sub-
tle interplay between binding and rigidity. Here, we focussed on the human
leucocyte antigen (HLA), which plays a crucial role in the adaptive
immune system by presenting peptides for recognition by the ab T-cell
receptor (TCR). The role that the peptide plays in tuning HLA flexibility
during TCR recognition is potentially crucial in determining the functional
outcome of an immune response, with obvious relevance to the growing list
of immunotherapies that target the T-cell compartment. We have applied
high-pressure/temperature perturbation experiments, combined with molec-
ular dynamics simulations, to explore the drivers that affect molecular flex-
ibility for a series of different peptide–HLA complexes. We find that
different peptide sequences affect peptide–HLA flexibility in different ways,
with the peptide cargo tuning a network of correlated motions throughout
the pHLA complex, including in areas remote from the peptide-binding
interface, in a manner that could influence T-cell antigen discrimination.
Abbreviations
APLs, altered peptide ligands; CAN, community network analysis; DCCMs, dynamic cross-correlation matrices; ER, endoplasmic reticulum;
FEL, free energy landscape; HLA, Human leucocyte antigen; MD, molecular dynamics; p/T, pressure/temperature; pHLAs, peptide–human
leucocyte antigens; RMSFs, root mean square fluctuations; TCR, T-cell receptor; Tm, melting temperatures.
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Introduction
The T-cell receptor (TCR), expressed on the surface of
T cells, scans for antigens on the surface of virtually
every cell in the body. TCR–antigen recognition can
mediate clearance of germs and neoplasms, and plays a
major role in autoimmunity and transplantation [1-5].
As such, a better understanding of the molecular deter-
minants that govern TCR–antigen interactions is key to
identifying novel therapeutic interventions that can
enhance (cancer immunotherapy, vaccines) or inhibit
(regulation of autoimmunity) T-cell activation. The nat-
ural TCR ligands are the peptide–human leucocyte
antigens (pHLA) class I and class II. Classically, pHLA
class I is recognised by CD8+ T cells, and pHLA class
II is recognised by CD4+ T cells. These ligands feature
a number of unique characteristics (analogous in both
the pHLA class I and pHLA class II systems) that have
important implications for both protein dynamics and
T-cell-mediated immunity. First, the antigen-binding
site is composed of a composite that includes the HLA-
binding groove (formed by the HLA a1 and a2
domains for HLA class I, the focus from here on in)
and a short 9- to 13-amino acid peptide that can be
derived from a completely unrelated protein (the source
of these peptides is generally the immune proteasome
that degrades the majority of intracellular proteins,
which can derive from foreign or mutated self-proteins)
[6,7]. Intriguingly for HLA class I, although the peptide
only accounts for ~ 2% of total amino acids in the
pHLA class I molecule, its position within the binding
groove ‘pins’ the entire complex together, that is HLA
class I molecules do not generally form a stable struc-
ture without a bound peptide [8]. These peptides are
edited by the antigen-processing machinery in the endo-
plasmic reticulum (ER) before being transported to the
cell surface for TCR interrogation [9]. Second, during
binding, the TCR interacts directly with both the HLA
surface and the peptide (composite antigen-binding site)
[10,11]. How the TCR retains the delicate balance
between HLA binding and peptide dependence (pep-
tide-independent recognition of HLA would result in T-
cell activation against virtually every nucleated cell in
the body) is still not fully understood. Finally, pHLA is
unique in biology because it can form a trimeric com-
plex with both the TCR and co-receptor molecules
(CD8 for pHLA class I and CD4 for pHLA class II)
[12-15]. Although the co-receptors bind to an invariant
site distal from the TCR, this interaction is known to
play a role in TCR thymic selection [16], and can tune
TCR cross-reactivity by altering T-cell potency [17,18].
Many studies have focused on understanding the rela-
tionship between the biophysical characteristics of the
TCR-pHLA interaction and T-cell potency [19-24], and
the role of TCR flexibility during pHLA engagement
[4,25-34]. These studies have demonstrated that the opti-
mal TCR-pHLA interactions can be mediated by a highly
flexible binding mode, probably contributing to the ability
of TCRs to recognise multiple different pHLAs [19,35-
39]. This flexibility has been observed in the flexible loops
that form the binding site of the TCR, contributing
towards the notion that TCRs ‘meld’ around the pHLA
surface during binding [40]. Although flexibility has also
been reported in both the HLA-bound peptide [41-45] and
the HLA helices [46-48], the role that different peptides
play in modulating HLA dynamics globally, and what
impact the dynamicsmight have onT-cell antigen recogni-
tion, is only beginning to be explored [49,50]. On the one
hand, a more dynamic pHLAmolecule could enable TCR
binding of the peptide cargo in an ‘optimal’ conformation
for T-cell activation, or to enable recognition by a greater
range of different TCRs. On the other hand, a more
dynamic pHLA may confer a higher entropic cost during
TCR binding that might reduce affinity, or could lead to
the unwanted recognition of self-antigens leading to
autoimmunity.
In the context of protein–protein and protein–ligand
interactions, molecular flexibility is defined by a multi-
dimensional free energy landscape (FEL), comprising a
large number of energetic minima and maxima that
define differently stable conformational substates of the
same protein (or protein complex). Peptide-dependent
effects on HLA dynamics could influence the functional
interaction between TCR and pHLA, as well as other
molecules known to interact with these receptors. As
suggested by others, we consider whether the nature of
the peptide cargo can alter the conformational states
that are accessible to the HLA molecule (i.e. its FEL).
To address this hypothesis, we use combined pressure/
temperature (p/T)-dependent fluorescence spectroscopy
and molecular dynamics (MD) simulations to expose
differences in the thermodynamics of the differing
pHLA complexes and to identify the atomistic determi-
nants of changes in pHLA flexibility. These data pro-
vide further insights into the role that the peptide plays
in tuning the flexibility of HLA, a feature that might
contribute to modulation of TCR–antigen recognition
and T-cell-mediated immunity.
Results and Discussion
Pressure/temperature matrices expose differing
thermodynamic contributions to pHLA flexibility
We focused on the well-characterised 1E6 TCR
system, a TCR that naturally recognises the
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HLA-A*02:01-restricted ALWGPDPAAA15-24 peptide
from the preproinsulin protein, and plays a biological
role in human type 1 diabetes [2,51-53]. We have pre-
viously reported a number of altered peptide ligands
(APLs) for the 1E6 TCR using structural, biophysical
and cellular analysis. These data demonstrated that,
despite a highly conserved, hotspot-driven binding
mode (Fig. 1A), the binding affinity and cellular
potency of the 1E6 TCR for the different APLs was
substantially affected, independently of pHLA stability
(Fig. 1B) [19]. Thus, this well-characterised set of
APLs provided a biological relevant model system to
further examine the contribution of the antigenic pep-
tide on HLA flexibility.
Molecular flexibility can be usefully thought of as
the transitions between different conformational states
(energetic minima) on the protein FEL. Combined
pressure/temperature (p/T) denaturation studies have
been used in a number of cases to extract the complete
suite of thermodynamic parameters that define the
FEL for protein folding, so-called elliptical phase dia-
grams [54]. In the present study, we wished to explore
the FEL specifically relating to native protein confor-
mational change. Nondenaturing hydrostatic pressure
is an excellent probe of native protein dynamics since
it acts by perturbing the pre-existing equilibrium of
states, favouring more compact conformations [55].
Nondenaturing pressure therefore gives access to the
conformational changes that are natively accessible on
the proteins FEL.
Intrinsic Trp emission is a ready reporter of the
effect of p/T perturbation because Trp emission inten-
sity and the structure of Trp emissions spectra are sen-
sitive to changes in the immediate molecular
environment through a range of mechanisms [56]. That
is, Trp emission spectra can provide accurate metrics
of changes in protein tertiary structure. Figure 2 shows
the emission spectra for the pHLA complexes used in
this study excited at 295 nm. These data show that the
structure of the Trp emission spectra is essentially
identical, as assessed by the fitting to a skewed Gaus-
sian model, which accurately tracks changes in struc-
ture of such spectra,
fi ¼ fmax expð ln 2Þ
ln 1þ 2b kEmk
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where fi is the measured fluorescence intensity, fmax is
the maximum emission intensity at wavelength kmaxEm ,
with a full width at half-maximal of w, and the ‘skew-
ness’ is given by b. From Fig. 2, fitting to Eqn 1 shows
that the emission maxima for each pHLA complex are
essentially identical (Fig. 2, inset), suggesting that the
tertiary structure of the pHLAs is similar and the dif-
ferent peptides have not induced a change in tertiary
structure. Moreover, that the kmaxEm values in Fig. 2 are
essentially invariant suggests that there is no significant
fraction of free HLA, which would otherwise be
unfolded and manifest a change in kmaxEm .
As above, changes in Trp emission are reporters of
protein conformational change and as such can be
used to calculate an equilibrium constant for the
change across a perturbation series. The change in Trp
emission can be converted to an equilibrium constant,
FiP
F
ðp; TÞ ¼ K ðp; TÞ
1þ K ðp; TÞ ð2Þ
A
B
Fig. 1. (A) Structural representation of the 1E6 TCR-pHLA
interaction with the inset showing a zoom-in on the TCR-pHLA
binding site. The conserved GPD motif in the peptide and TCR
residues that interact with these residues are shown as sticks. For
the 4 peptides that also interact with the TCR via their position 1
residue (X), the side chain of this residue is also indicated with
orange sticks. Images were generated with PyMOL 1.8.6 [88]. (B)
Peptide sequences and their respective pHLA melting
temperatures (Tm) as determined by CD spectroscopy (reported
previously [19]). The central conserved GDP motif is coloured blue,
and the altered peptide residues with respect to the index
ALWGPDPAAA peptide are shown in red.
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where Fi is the integral of the emission intensity of Trp
for a given p/T. For a simple 2-state transition, for
example an equilibrium between 2 conformational sub-
states, the temperature dependence of the equilibrium
constant is given by,
lnK ¼ ðDGÞ=RT ð3Þ
The combined p/T dependence of DG reflects the
free energy difference between the 2 notional substates
and so is a proxy for the degree of conformational
‘flexibility’. DGP,T is then given by,
DGP;T ¼ DG0 þ DV0ðP P0Þ þ Da0ðP P0ÞðT T0Þ
þ Db
0
2
ðP P0Þ2  DS0ðT T0Þ
 DCP T ln T
T0
 
 1
 
þ T0
  ð4Þ
where T0 is a reference temperature. DH, DS, DG0,
DCp, DV0, Db and Da reflect the changes in enthalpy,
entropy, Gibbs free energy, heat capacity, activation
volume, compressibility and expansivity between the 2
notional conformational substates that define the equi-
librium, respectively. Note that this model assumes
both DCp and Da are constant with respect to both
pressure and temperature. The model further assumes a
two-state transition because the model for a more com-
plex number of states would be intractable when fitting
the experimental data. We note that one expects a far
larger number of conformational substates to be pre-
sent, since the FEL is composed of ever more discrete
local minima. However, the assumption of a two-state
system provides a means to explore and compare major
differences in protein flexibility without overfitting the
data. The data in Fig. 3 show a reasonable fit to the
Eqn 4 as assessed from the relatively high R2 values
(all > 0.965) and given the residuals of the fits (Fig. 3;
bottom panels). Moreover, none of the fitting parame-
ters were directly dependent on one another as assessed
from the variance–covariance matrix. The quality of
the fit in each case is reflected in the associated error of
the fitted parameters (Table 1).
These analyses demonstrated that the p/T relation-
ship clearly differed for different pHLA complexes
(Fig. 3, Table 1). The contribution of the different
thermodynamic parameters to the magnitude of DG
was highly specific for each peptide sequence. For
example, with RQFa and RQFi, the contribution from
DS was large compared with other parameters; for
ALW, the contribution from DCp was large compared
with other parameters. MVW, RQW and YQF pep-
tides had significant contributions from DV0 and Db,
which were not observed for RQFa, RQFi and ALW
peptides. We caution that we have not been able to
monitor the concentration of free HLA at different
pressures and so our data could conceivably be con-
volved of some fraction of free HLA. That said, free
HLA is known to be extremely unstable [57,58] and
we found our pressure dependence data to be fully
reversible, suggesting that if any dissociation occurred
on the timescale of the experiment it was not obvi-
ously detectable and so by inference, small.
The significant differences in the magnitude of DCp
are particularly notable given that a major contribution
to DCp for large protein conformational changes and
protein folding is the difference in hydration state
between the conformational states that are accessed
[59]. Similarly, studies with model systems have found
that the magnitude and sign of Da is sensitive to the
solvation environment (changes to water structure)
[60]. Zero values of Da imply a ‘rigid’ protein, and pos-
itive Da values are correlated with exposure of
hydrophobic residues [61]. Whilst there were some dif-
ferences outside of error for Da for the specific pHLAs,
we note the large error on these values. That the mag-
nitude of DCp varies significantly (including sign inver-
sions) suggests each pHLA explores conformational
substates with unique hydration states, and this implies
each pHLA samples unique conformational substates
within an equilibrium population. Despite the implied
differences in conformational flexibility, the magnitude
of DG0 (Table 1) can be similar for the different
pHLAs. We interpret these data, taken together, as
reflecting that the conformational substates explored
Fig. 2. pHLA Trp emission spectra (excited at 295 nm). Solid
transparent lines are the fits to Eqn 1. Inset, resulting values for
kmaxEm extracted from fits to Eqn 1. YQF is shown in grey, ALW is
shown in blue, RQW is shown in black, MVW is shown in red,
RQFi is shown in green and RQFa is shown in yellow.
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by each pHLA are different, but the population distri-
butions across those states are similar.
The p/T data point to a peptide sequence-specific
effect on the FEL reflecting HLA conformational
flexibility. That is, different peptide sequences affect
pHLA molecular flexibility in different ways. Most
intriguingly, our data suggest the peptide–HLA inter-
action is governed by a complex interplay of a range
Fig. 3. Combined p/T matrices for each pHLA studied. Solid spheres represent the experimental data, transformed to DG as Eqn 3. The
coloured surfaces are then the resulting fit of these values to Eqn 4. Each panel is labelled as the specific pHLA complex. The grey panels
(bottom) show the corresponding residuals for each fit labelled with the associated pHLA complex as the main panels. Red and blue
contour lines are the + and  25% limits, respectively. The concentration of pHLA in each experiment was between 6 and 12 µM (0.3–
0.5 mgmL1), adjusted to give the best signal in the fluorimeter without inducing the inner filter effect.
Table 1. Parameters extracted from surface fits shown in Fig. 2. Tm values previously published [19]
Tm
(oC)
DG0
(kJmol1) DS (kJmol1)
DCp
(kJmol1K1)
DV
(cm3mol1) 9 103
Db
(cm3mol1mPa1) 9 105
Da
(K1) 9 105
RQFi 58.8 8.1  0.1 0.07  0.6 0.6  0.2 2  1 1.3  1.1 3.4  3.5
YQF 60.3 8.3  0.1 0.02  0.33 0.3  0.3 5  1 3.6  1.5 8.5  4.9
RQW 54.3 8.7  0.2 0.04  0.02 0.6  0.4 4  2 2.4  2.1 5.0  6.7
RQFa 49.4 8.8  0.1 0.06  0.01 0.3  0.2 0  1 6.3  1.0 1.1  3.1
ALW 60 8.7  0.2 0.01  0.02 1.7  0.3 0  2 7.1  2.0 4.6  6.3
MVW 56.7 8.8  0.2 0.06  0.02 0.0  0.4 6  2 4.8  2.4 8.7  7.7
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of different thermodynamic contributions, which do
not have an obvious relationship to peptide sequence.
Molecular dynamics simulations identify both
local and distal changes in flexibility for different
peptide cargos
The p/T analysis demonstrated significant differences
in the global molecular flexibility and thermodynamics
of the pHLA binary complexes, dependent on the pep-
tide cargo. In an attempt to rationalise the differences
observed experimentally, we used MD simulations,
performing 10 replicas of 150 ns each for each pHLA
under investigation, giving a total of 9 µs of simula-
tion time. Using this approach, the (backbone) flexibil-
ity of the pHLA can be inferred by calculating the
root mean square fluctuations (RMSFs) of each resi-
due’s Ca carbon over the course of the simulations.
To investigate the impact of different peptide cargos
on the flexibility of the HLA, we first calculated the
Ca RMSF for the peptide and the a1 and a2 domains
of the pHLA (Fig. 4). We then extended this analysis
to the a3 and b2m domains for each pHLA (Fig. 5).
As we were primarily interested in the differences in
pHLA flexibility with different peptide cargos, we cal-
culated the average RMSF value for each residue in
all complexes, and subtracted this from each pHLA
complex RMSF value, meaning that a residue with a
positive DRMSF value indicates an increased flexibility
compared with the average. We evaluated the signifi-
cance of the DRMSF differences observed by perform-
ing a two-sample t-test between the most and least
rigid pHLA molecules for each position.
Significant differences (P < 0.05) were observed for
only 2 of the peptide residues (of 10 total). Interest-
ingly, flexibility differences were not necessarily corre-
lated with regions of the peptide that differed between
APLs, demonstrating the interconnected nature of the
peptide. For instance, the N-termini had largely very
similar flexibility (with the exception of RQW), despite
the N-terminal residues differing substantially between
peptides. In contrast, DRMSF analysis of the central
‘GPD’ motif of peptide (known to be the main binding
site for the TCR and conserved in all APLs investi-
gated in terms of sequence and conformation) demon-
strated significant changes in flexibility, particularly
between RQW and MVW, which showed increased
and decreased flexibility relative to the average, respec-
tively. This is of particular interest as the conserved
‘GPD’ motif accounts for 41-50% of all contacts
between the 1E6 TCR and the 6 pHLA complexes
investigated [19]. These changes in peptide flexibility
could, therefore, have a direct impact on the
interaction between the TCR–pHLA complexes (for
instance by modulating the entropic cost of binding).
In contrast to the peptides, which demonstrated rela-
tively small changes in flexibility, significant differences
(P < 0.05) in flexibility were detected in 45 residues
(out of 180 total) for the a1 and a2 helices, 35 residues
(out of 97 total) in the a3 domain and 54 residues (out
of 100 total) in the b2m domain of the HLA. Whilst it
is possible that additional HLA residues show differ-
ences in flexibility for different peptide cargos, our
results demonstrate the importance of performing
many replicas and statistical analysis on those replicas
to prevent the observation of what may be false posi-
tives [62]. The observed significant differences in flexi-
bility were largely confined to the solvent-exposed
loops in the HLA domains, including loops 3 and 5 in
the a1 and a2 domains, respectively. These loops are
known to play a role during interactions with tapasin
and TAPBPR during peptide editing in the ER [63,64].
A comparatively smaller number of residues that make
up the a1, a2 and a2-1 helices of the peptide-binding
groove showed significantly different flexibilities. These
differences were limited to a central region of the a1-
helix (residues 68–72), the C-terminal portion of the
a1-helix (residues 80–85) and the middle of the a2-helix
(residues 160–162). Additionally, loops 8 and 10 on the
a3 domain and loop 6 on the b2m domain, which are
known to play a role in interactions with the CD8 co-
receptor [12], demonstrated high degrees of differences
in flexibility. We also note that the statistically signifi-
cant changes in flexibility we detected in loop 10 in the
a3 domain with different peptide cargos are consistent
with a previous report demonstrating flexible tuning of
this loop during peptide binding [50]. Thus, these
changes in flexibility, dependent on peptide cargo,
could play a role in tuning the antigen-processing path-
way, or in modulating the interaction with the CD8
co-receptor, which is known to play a key role in alter-
ing T-cell potency and cross-reactivity [17,65-67]. Over-
all, differences in flexibility identified by MD analysis
were largely observed in the HLA, despite the differ-
ences in sequence being confined to the peptide cargo.
This unexpected finding of ‘the tail wagging the dog’
may be indicative of allosteric mechanisms in which
the sequence of the peptide modulates regions of the
HLA known to play a role in different immunological
pathways.
Peptide-dependent changes in the binding groove
geometry
Whilst our RMSF calculations on the HLA residues
that make up the peptide-binding site (Fig. 4) identified
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many of the decorating loops to show significantly dif-
ferent flexibilities dependent on the peptide cargo, dif-
ferences in the flexibility of HLA residues on the a1, a2
and a2-1 helices were largely insignificant. This sug-
gests that their (backbone) mobility is highly similar, at
least for the peptides studied here. However, whilst
these residues may have similar mobilities, they may
sample different ranges of conformational space
depending on the peptide bound (and thus modulated
by the peptide sequence). A peptide-dependent effect
on the groove width (distance between the binding
groove helices) has indeed been observed previously in
similar systems [49-50,68-70]. Of particular importance
may be the peptide-dependent modulation of the
A B
C
Fig. 4. Differences in flexibility in the HLA and the peptide for all 6 pHLA complexes investigated. (A, B) Change in Ca RMSF (average –
pHLA) for the a1 and a2 domains (A) and peptide (B), meaning a positive DRMSF value indicates an increase in rigidity for that pHLA
complex residue relative to the average. The black dots towards the bottom of each graph indicate residues with significantly different
DRMSF values as determined by a two-sample t-test (P < 0.05). (C) DRMSF values as shown in A–B colour mapped on the pHLA structure
(HLA as cartoon, peptide as ball and stick), with blue indicating increasing rigidity and red indicating increasing flexibility (again relative to the
average RMSF value for that residue). Heat mapping is scaled from –0.5 to 0.5 A for all complexes. Images were generated with PYMOL
1.8.6 [88].
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C-terminal binding site groove widths (located near the
break between the a2 and a2-1 helices); the a2-1 helix
was indicated to ‘swing out’ in order for peptide editing
to occur with the chaperones Tapasin or TAPBPR [63-
64,71,72]. Comparison of the binding groove widths
sampled for each pHLA complex studied here (Fig. 6)
shows clear evidence of peptide-dependent modulation,
both in terms of the average binding groove distance
A B
C
Fig. 5. Differences in flexibility in the HLA molecules outside of the peptide-HLA binding groove for all 6 pHLA complexes investigated.
(A, B) Change in Ca RMSF (average – pHLA) for the a3 domain (A) and b2m (B), meaning a positive DRMSF value indicates an
increase in rigidity for that pHLA complex residue relative to the average. The black dots towards the bottom of each graph indicate
residues with significantly different DRMSF values as determined by a two-sample t-test (P < 0.05). (C) DRMSF values as shown in A–
B colour-mapped on the pHLA structure, with blue indicating increasing rigidity and red indicating increasing flexibility (again relative to
the average RMSF value for that residue). Heat mapping is scaled from –0.5 to 0.5 A for all complexes. Images were generated with
PYMOL 1.8.6 [88].
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and in terms of range of distances sampled. Of particu-
lar note, both ALW and MVW sample a much tighter
distribution of binding groove widths towards both the
N-terminal and central portions of the peptide (D1, D2
and D3) as compared to RQW. Focussing on sequence-
specific effects, residues with a bulky position 1 residue
(RQFa, RQW, RQFi and YQF) tend to sample larger
groove widths towards the N-terminal binding site, as
expected (D1 in Fig. 6). The size of D2 appears to be
regulated primarily by position 3 of the peptide, with
tryptophan-containing peptides (MVW, ALW and
RQW) sampling larger groove widths as compared to
phenylalanine containing peptides (RQFa, YQF and
RQFi). For the remaining two groove widths investi-
gated (D3 and D4), whilst there are clear differences in
conformational sampling for the different pHLA com-
plexes, the large differences between the peptide
sequences preclude assigning specific effects to specific
residues/positions. Interestingly, two different substates
in measurement D4 are observed for all peptides bar
RQFi. These different states relate to the degree to
which the a2-1 helix has swung out from the a1-helix,
and peptide-dependent regulation of the sampling of
these two states is likely important for regulating pep-
tide editing (see Results and Discussion above).
Identification of correlated motions between the
peptide and HLA
With the observed significant differences in flexibility
for regions both local and distal from the peptide-
binding site in mind, we computed dynamic cross-cor-
relation matrices (DCCMs) for all 6 pHLAs under
investigation. DCCMs measure the degree of corre-
lated motion between each atom (in this case the Ca
carbon of each residue) over the course of the simula-
tion(s). The measurement assigns a value between +1
(perfectly correlated motion) and –1 (perfectly anticor-
related motion), with 0 indicating no correlation
between the residues. This analysis can therefore be
used to identify residues distal from one another that
are dynamically linked. To focus primarily on the rela-
tionship between the peptide and the HLA, we trun-
cated the obtained DCCMs to allow for easier analysis
of their relationship (Fig. 7). Large differences in the
overall degree of correlated motion between the pep-
tide and HLA occur, with RQW most strikingly show-
ing a decreased level of correlated motion. Further, a
much larger degree of coupling between the C-terminal
end of the peptide and the rest of the HLA is
observed, as compared to the N-terminus and central
portion of the peptide. Thus, these data suggest that
the C-terminal residues of the peptide may play a
more important role in regulating the global dynamics
of the HLA, possibly via the F-pocket of the HLA-
binding groove. In particular, we observed consistently
positively correlated motion between the C-terminal
residues of the peptide and the a1 helix as well as resi-
dues 114–134, which make up a large part of the F-
pocket. Interestingly, we also observed a consistent
change across all pHLA complexes of positively corre-
lated-to-anticorrelated motion along the a2 helix (posi-
tive starting at the a2-1 portion of the helix). The
degree of correlation between the peptide and domains
distal from the peptide-binding site (a3 and b2m
domains) also showed consistent regions of correlated
motions for different pHLA complexes. Whilst in the
case of RQW, and to a lesser extent RQFa, these cor-
relations were weaker, and residues within the range
210-250 on the a3 domain showed correlated motion
to the peptide. These residues include those in loop 10,
which we herein, and others [50], observed significant
differences in flexibility dependent on the peptide
cargo.
Peptide-dependent tuning of the allosteric
communication network
The observed differences in flexibility and correlated
motions for different peptide cargos in the HLA point
to an allosterically linked network across the pHLA
complex. With this in mind, we turned to community
network analysis (CNA) [73] to determine the mecha-
nisms by which the peptide communicates dynamical
changes to regions distal from the binding site. In
CNA, residues are grouped into ‘communities’ of simi-
lar dynamics (communities are groups of residues local
to one another that share highly correlated motions).
The strength of the communication pathway between
different communities is determined by the overall
amount of correlated motion between members of the
2 given different communities. These data can there-
fore be represented in graphical form, in which a node
corresponds to a community (with the size of the node
indicating the number of residues in that community),
and edges between nodes indicating the strength of the
communication pathway (with an increased thickness
indicating increased correlation) (Fig. 8). The pHLA
complexes were partitioned into 9 communities each
(chosen based on a consistently high modularity score
and an ability to partition the different pHLA com-
plexes as similarly as possible), apart from RQW,
which was partitioned into 10 communities because
the first 6 residues of the peptide consistently grouped
into their own community even at much lower overall
community numbers (see Materials and methods for
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further information). All communities located in the
peptide-binding groove (peptide and a1 and a2
domains) were highly interconnected to one another.
Communication from the binding groove to the b2m
domain appeared to occur through a single commu-
nity, generally located towards the end of the a1 helix
Fig. 6. Differences in the HLA-binding groove widths for all 6 pHLA complexes simulated. (A) Visual representation of the residues selected
for each measurement, with an exemplar peptide shown for reference (the peptide N-terminus is located on the left-hand side of the
figure). For all four measurements, the centre of mass of 3 Ca carbon atoms on each helix is used for the measurement. Images were
generated with PYMOL 1.8.6 [88]. (B) Violin plots based on histograms of the groove widths sampled in MD simulations as labelled in A with
RQFi shown in yellow, YQF shown in mauve, RQW shown in green, RQFa shown in blue, ALW shown in red and MVW shown in black.
Plots show the distribution of groove widths sampled by the HLA at the four individual measurement points (as shown in A).
Fig. 7. Dynamic cross-correlation matrices (DCCMs) for all 6 pHLA complexes simulated. On the y-axis is each residue of the peptide,
which is plotted against all other residues (377 total) on the HLA. The matrices are colour-mapped according to the degree of correlated
motion between the two residues, with a value of +1 meaning perfectly correlated and –1 meaning perfectly anticorrelated motion.
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and part of the residues that form the F-pocket (pep-
tide C-terminal binding site). This contrasted with
observations made for the top portion of the a3
domain, in which multiple communities in the peptide-
binding groove showed a significant level of directly
correlated communication with residues belonging to
the a3 domain. These observations may help to ratio-
nalise why the C-terminal peptide residues tended to
show a much greater degree of correlated motions with
HLA residues. That is, the residues responsible for
binding the C-terminal portion of the peptide appear
to be dynamically linked to both the a3 and b2m
domains, in contrast to the residues responsible for
binding the N-terminal portion of the peptide.
The above results are supported by a previous study
on how different peptides were able to modulate the
flexibility of loop 10 in the a3 domain [50]. In this pre-
vious study, the major communication pathway found
was from the C-terminal binding site through to the
top portion of the b2m domain and then into the a3
domain. This observation compares well with our
community network analysis across all complexes stud-
ied here, revealing a highly similar communication
pathway from the C-terminal binding site to the a3
Fig. 8. Peptide-dependent tuning of the allosteric communication network. Community networks determined for all pHLA complexes
studied. Networked communities are shown as coloured spheres, with the radii of the sphere indicating the number of residues within the
community. Edges between the nodes/communities represent communication pathways between the nodes, with the thickness of the
edge indicating the degree of correlation between the two communities (thicker = greater correlation). All pHLA complexes are shown from
the same orientation, such that N-terminus of the peptide is in the foreground.
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domain (from the cyan to the dark blue and then to
dark green communities in Fig. 8).
Conclusions
Here, we used cutting edge experimental approaches
and molecular dynamics simulations to demonstrate
that the peptide cargo is able to tune the conforma-
tional dynamics of HLA. More specifically, the precise
amino acid composition of the peptide cargo differen-
tially engages a network of correlated protein dynam-
ics that spans the HLA. For instance, the C-terminus
of the peptide appears to be able to regulate the con-
formational dynamics of the entire pHLA complex as
well as the main TCR–peptide contact zone, poten-
tially modulating TCR binding. Our data point to the
peptide cargo having the ability to tune a network of
allosteric dynamics in the pHLA complex and may
play a role in tuning a number of pathways involved
in T-cell-mediated immunity. These include peptide
editing during antigen processing, interactions with the
CD8 co-receptor, and direct TCR interactions with the
peptide and HLA. These findings may be pertinent for
peptide vaccine design and may help explain why even
minor alterations in peptide sequence can completely
alter the direction of the immune response [44,74,75].
Our study also has broader implications for the under-
standing of protein interaction networks, particularly
allosteric mechanisms, in which changes in a relatively
small component of the protein complex (in this case a
few mutations in a 10-amino acid peptide) can a mod-
ulate flexibility distal to the changes and throughout
the complex (in this case, HLA, a 4-domain protein
complex, made up of nearly 400 amino acids).
Materials and methods
Protein expression and refolding
HLA-A*02:01 and b2m were expressed and refolded using
competent BL21 DE3 E. coli cells transfected with pGMT7
expression plasmids as previously described [76,77].
Refolded protein was purified by anion exchange using a
Poros 50HQ column, followed by size exclusion into phos-
phate-buffered saline using gel filtration column – Super-
dexTM 200 Increase 10/300 GL. Purification followed a
previously described protocol [76,77]. Dynamic light scatter-
ing (Zetasizer, Malvern Products, Malvern, UK) was used
to confirm sample homogeneity. For pressure/temperature
varying fluorescence measurements, samples were exchanged
into a HEPES buffer (50 mM HEPES, 150 mM NaCl, pH
7.4) using a PD-10 desalting column containing SephadexTM
G-25 medium, following manufacturer instructions. We
note that the refolding of HLA, in the presence of peptide,
with subsequent purification, excludes uncomplexed pHLA.
Pressure/temperature-dependent fluorimetry
Pressure/temperature measurements were performed using
an ISS high-pressure cell (ISS, Champaign, IL, USA) fitted
with a custom fibre optic mounting connecting to the fluo-
rimeter and the water bath. Peptide–HLA complexes were
excited at 295 nm, and tryptophan emission was measured
between 325 and 500 nm. Emission and excitation slits were
set to 15 nm to minimise the signal-to-noise ratio (due to
optimal setup of the pressure cell). Initial measurements
were made at 10 °C and increased in 5 °C increments up to
30 °C. The pressure dependence at each temperature was
measured at 50, 400, 800, 1200 and 1600 bar. Measurements
were taken in triplicate. Following each full pressure/tem-
perature range, repeat scans were taken at lower pressure/
temperature conditions to ensure extreme pressure/tempera-
ture conditions had not denatured the protein. For all mea-
surements, the appropriate buffer controls were subtracted
prior to data processing. Fitting Eqn 4 to the data gave typ-
ical R2 values > 0.965. Fitting was achieved using ORIGINPRO
(OriginLab). The concentration of pHLA in each experi-
ment was between 6 µM and 12 µM (0.3–0.5 mgmL1),
adjusted to give the best signal in the fluorimeter without
inducing the inner filter effect. The values given in Table 1
are the result of three experimental replicates. The data are
fit to Eqn 4 accounting for the standard deviation of each
data point. The resulting parameters extracted from the
data (Table 1) show the error calculated from the fit.
MD simulations
Previously solved X-ray crystal structures of the 6 pHLA
complexes (PDB I.D.s: 3UTQ, 5C0E, 5C0F, 5C0H, 5C0I
and 5C0J) [2,19] were used as the starting point for all MD
simulations. Any missing residues were added using MOD-
ELLER v9 [78]. PROPKA 3.0 [79] was used to predict the pro-
tonation states of all proteins investigated at pH 7
(resulting in all residues being simulated in their standard
protonation states). MolProbity [80] was used to determine
the optimum tautomerisation states for every His residue
and make any required Asn/Gln side-chain flips (under the
criteria of optimising the hydrogen bonding network). The
results were visually inspected, and care was taken to
ensure consistency between all pHLAs investigated. His-
tidine residues 4, 71, 115, 189, 193, 261 (Chain A) and 51
(Chain B) were simulated as singly protonated on their
Nd1 nitrogen, with all other histidine residues simulated as
singly protonated on their Ne2 nitrogen. All systems were
then solvated in an octahedral water box (retaining any
crystal waters) such that no protein atom was within 10 A
of the box boundary. Simulations were performed at an
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effective [NaCl] of 150 mM (to match experiments), with
excess Na+ ions added as required to ensure neutrality.
MD simulations were performed using Amber16, describing
the protein and water molecules with the ff14SB force field
[81] and TIP3P water model [82], respectively. Following a
protocol of minimisation, heating and equilibration (see
section ‘Structure equilibration procedure’ below), all
pHLA complexes were subjected to 10 9 150 ns of produc-
tion MD simulations in the NPT ensemble (at 300 K and
1 atm), with snapshots collected every 10 ps. Production
MD simulations were performed using a 2 fs time step and
with the SHAKE algorithm applied. An 8 A direct space
nonbonded cut-off was applied with long-range electrostat-
ics evaluated using the particle mesh Ewald algorithm [83].
Temperature was regulated using Langevin temperature
control (collision frequency of 1 ps1), whilst pressure was
controlled with a Berendsen barostat (setting the pressure
relaxation time to 1 ps).
MD trajectory analysis
Routine trajectory analysis was performed with CPPTRAJ
[84]. Ca RMSF calculations were performed for all com-
plexes after discarding the first 10 ns of simulation time
(for equilibration) and averaged over each run. RMS fit-
ting was performed to the Ca of stable (over the course of
our MD simulations) secondary structure residues of the
HLA. We used the following residues for RMS fitting: 4–
13, 22–38, 51–54, 58–86, 95–104, 111–127, 134–181, 187–
196, 199–209, 215–220 and 242–263 of Chain A (i.e. the
a1, a2 and a3 domains), and residues 6–11, 21–30, 36–41,
60–70, 78–83 and 91–94 of Chain B (i.e. the b2m domain).
For RMSF, DCCM and CNA calculations, RMS fitting
was first performed to the crystal structure in order to cre-
ate an average structure. Following this, all snapshots were
then refitted to the average structure for the subsequent
calculations. DCCMs and CNA were calculated using a
combination of the Bio3D [85] and igraph [86] libraries
within the package R. Briefly, all 10 independent simula-
tions were combined into a single trajectory, RMS fitting
each frame to an average structure of all ten simulations
combined. DCCMs were calculated for all 387 9 387 resi-
dues in each pHLA before truncating the matrix to show
the degree of correlated motion between the peptide and
all HLA residues. CNA was performed on the aforemen-
tioned complete DCCM results, using a Girvan–Newman
clustering protocol [73] to cluster communities of similar
dynamics together. Edges with a correlation score of < |
0.4| were discarded prior to clustering. The resulting com-
munities were further filtered using a maximum distance
cut-off between pairs of atoms of 8 A (throughout 100%
of the simulation time). Whilst the standard procedure in
CNA is to plot the community number that gives the high-
est modularity, it is also acceptable when comparing multi-
ple similar complexes, to choose a high scoring
modulatory value that better groups the resulting struc-
tures [87]. The modularity is a measure of the level of
interconnectedness between community members, and the
level of correlation with noncommunity members, with a
higher score indicating increased intercommunity correla-
tion and decreased intracommunity correlation, and there-
fore a better division of the data. We choose a community
number of 10 for RQW and 9 for all other pHLA com-
plexes based on the above criteria, and in all cases, the dif-
ference between the maximal possible modularity score
and the selected community score was no greater than
0.02. A value of 10 was selected for RQW as the N-termi-
nal portion of the peptide consistently grouped to itself
even at much lower community numbers (lowest evaluated
community number was 4).
Structure equilibration procedure
Upon preparation of all six pHLA complexes investigated,
the following procedure was used to equilibrate structures
for production MD simulations performed at 300 K and
1 atm: minimisation of all hydrogen atoms and solvent
molecules (including Na+ and Cl), using 500 steps of
steepest descent followed by 500 steps of conjugate gradi-
ent. To keep all other atoms (i.e. the protein heavy atoms)
in place during the minimisation, 10 kcalmol1A1 posi-
tional restraints were applied. Retaining the positional
restraints on all protein heavy atoms, the system was then
heated rapidly from 50 to 300 K in the NVT ensemble
over the course of 200 ps. This system was again min-
imised for a further 500 steps of steepest descent followed
by 500 steps of conjugate gradient, this time only applying
positional restraints (of 5 kcalmol1A1) to the Ca car-
bon atoms. These Ca restraints were retained as the sys-
tem was again heated from 25 to 300 K over the course of
50 ps in the NVT ensemble. Simulations were then per-
formed in the NPT ensemble (1 atm, 300 K), first gradu-
ally reducing the 5 kcalmol1A1 Ca carbon restraints
over the course of 50 ps of simulation time. This was done
in 5 steps (5, 4, 3, 2, 1 kcalmol1A1) of 10 ps each. A
final 1 ns simulation was then performed in which no
restraints were used. The end structure from this run was
then used as the starting structure for a production MD
simulation. All dynamics steps used the SHAKE algo-
rithm. Simulations performed in the NVT ensemble used
Langevin temperature control (with a collision frequency
of 1 ps1) and used a simulation time step of 1 fs. Simula-
tions performed in the NPT ensemble again used Langevin
temperature control (collision frequency of 1 ps1) and a
Berendsen barostat (1 ps pressure relaxation time), with a
simulation time step of 2 fs. Simulations of replicas were
performed by taking the structures after the second min-
imisation step (and before the second heating step). Repli-
cas were therefore assigned different random velocity
vectors on the subsequent heating step.
13The FEBS Journal (2020) ª 2020 Cardiff University. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
J. R. Hopkins et al. Peptide cargo tunes HLA dynamics
Acknowledgements
JRH’s PhD studentship is funded by the MRC (MR/
N013794/1). RMC’s PhD studentship is funded by the
EPSRC. AKS is a Wellcome Senior Investigator
(WT100327MA). MWvdK is a BBSRC David Phillips
Fellow (BB/M026280/1). DKC was a Wellcome Career
Development Fellow (WT095767). This research made
use of the Balena High-Performance Computing
(HPC) Service at the University of Bath as well as the
computational facilities of the Advanced Computing
Research Centre of the University of Bristol.
Author contributions
JRH, DAMC, DKC and CRP performed and/or
directed experiments. RMC and MWvdK performed
and/or directed simulations. JRH, RMC, DAMC,
AKS, VLA, MWvdK, DKC and CRP analysed data
and critiqued the manuscript. MWvdK, DKC and
CRP conceived and directed the project. JRH, RMC,
MWvdK, DKC and CRP wrote the manuscript.
Conflict of interest
DKC is an employee of Immunocore LTD. The authors
declare that the research was conducted in the absence
of any other commercial or financial relationships that
could be construed as a potential conflict of interest.
References
1 Coppieters KT, Dotta F, Amirian N, Campbell PD,
Kay TWH, Atkinson MA, Roep BO & von Herrath
MG (2012) Demonstration of islet-autoreactive CD8 T
cells in insulitic lesions from recent onset and long-term
type 1 diabetes patients. J Exp Med 209, 51–60.
2 Bulek AM, Cole DK, Skowera A, Dolton G, Gras S,
Madura F, Fuller A, Miles JJ, Gostick E, Price DA
et al. (2012) Structural basis for the killing of human
beta cells by CD8+ T cells in type 1 diabetes. Nat
Immunol 13, 283–289.
3 Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E,
Price DA, Gao GF, Jakobsen BK & Sewell AK (2009)
Germ line-governed recognition of a cancer epitope by
an immunodominant human T-cell receptor. J Biol
Chem 284, 27281–27289.
4 Cole DK, Fuller A, Dolton G, Zervoudi E, Legut M,
Miles K, Blanchfield L, Madura F, Holland CJ, Bulek
AM et al. (2017) Dual molecular mechanisms govern
escape at immunodominant HLA A2-restricted HIV
epitope. Front Immunol 8.
5 Archbold JK, Macdonald WA, Miles JJ, Brennan RM,
Kjer-Nielsen L, McCluskey J, Burrows SR & Rossjohn
J (2006) Alloreactivity between disparate cognate and
allogeneic pMHC-I complexes is the result of highly
focused, peptide-dependent structural mimicry. J Biol
Chem 281, 34324–34332.
6 Madden DR, Garboczi DN & Wiley DC (1993) The
antigenic identity of peptide-MHC complexes: a
comparison of the conformations of five viral peptides
presented by HLA-A2. Cell 75, 693–708.
7 Collins EJ, Garboczi DN &Wiley DC (1994) Three-
dimensional structure of a peptide extending from one
end of a class I MHC binding site. Nature 371, 626–629.
8 Saini SK, Tamhane T, Anjanappa R, Saikia A,
Ramskov S, Donia M, Svane IM, Jakobsen SN,
Garcia-Alai M, Zacharias M et al. (2019) Empty
peptide-receptive MHC class I molecules for efficient
detection of antigen-specific T cells. Sci Immunol 4,
eaau9039.
9 Momburg F & Tan P (2002) Tapasin – the keystone of
the loading complex optimizing peptide binding by
MHC class I molecules in the endoplasmic reticulum.
Mol Immunol 39, 217–233.
10 Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE
& Wiley DC (1996) Structure of the complex between
human T-cell receptor, viral peptide and HLA-A2.
Nature 384, 134–141.
11 Garcia KC, Degano M, Stanfield RL, Brunmark A,
Jackson MR, Peterson PA, Teyton L & Wilson IA
(1996) An alphabeta T cell receptor structure at 2.5 A
and its orientation in the TCR-MHC complex. Science
274, 209–219.
12 Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael
AJ, Stuart DI, Bell JI, Jones EY & Jakobsen BK (1997)
Crystal structure of the complex between human
CD8alpha(alpha) and HLA-A2. Nature 387, 630–634.
13 Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T,
Zhang R, Joachimiak A & Reinherz EL (2001) Crystal
structure of the human CD4 N-terminal two-domain
fragment complexed to a class II MHC molecule. Proc
Natl Acad Sci USA 98, 10799–10804.
14 Yin Y, Wang XX & Mariuzza RA (2012) Crystal
structure of a complete ternary complex of T-cell
receptor, peptide-MHC, and CD4. Proc Natl Acad Sci
USA 109, 5405–5410.
15 Cole DK, Dunn SM, Sami M, Boulter JM, Jakobsen
BK & Sewell AK (2008) T cell receptor engagement of
peptide-major histocompatibility complex class I does
not modify CD8 binding. Mol Immunol 45, 2700–2709.
16 Van Laethem F, Sarafova SD, Park J-H, Tai X,
Pobezinsky L, Guinter TI, Adoro S, Adams A,
Sharrow SO, Feigenbaum L & et al. (2007) Deletion of
CD4 and CD8 coreceptors permits generation of
alphabetaT cells that recognize antigens independently
of the MHC. Immunity 27, 735–750.
17 Wooldridge L, Laugel B, Ekeruche J, Clement M, van
den Berg HA, Price DA & Sewell AK (2010) CD8
14 The FEBS Journal (2020) ª 2020 Cardiff University. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
Peptide cargo tunes HLA dynamics J. R. Hopkins et al.
controls T cell cross-reactivity. J Immunol 185, 4625–
4632.
18 Hutchinson SL, Wooldridge L, Tafuro S, Laugel B,
Glick M, Boulter JM, Jakobsen BK, Price DA & Sewell
AK (2003) The CD8 T cell coreceptor exhibits
disproportionate biological activity at extremely low
binding affinities. J Biol Chem 278, 24285–24293.
19 Cole DK, Bulek AM, Dolton G, Schauenberg AJ,
Szomolay B, Rittase W, Trimby A, Jothikumar P,
Fuller A, Skowera A et al. (2016) Hotspot autoimmune
T cell receptor binding underlies pathogen and insulin
peptide cross-reactivity. J Clin Invest 126, 2191–2204.
20 Bridgeman JS, Sewell AK, Miles JJ, Price DA & Cole
DK (2012) Structural and biophysical determinants of
ab T-cell antigen recognition. Immunology 135, 9–18.
21 Aleksic M, Liddy N, Molloy PE, Pumphrey N,
Vuidepot A, Chang K-M & Jakobsen BK (2012)
Different affinity windows for virus and cancer-specific
T-cell receptors: implications for therapeutic strategies.
Eur J Immunol 42, 3174–3179.
22 van der Merwe PA & Davis SJ (2003) Molecular
interactions mediating T cell antigen recognition. Annu
Rev Immunol 21, 659–684.
23 Schmid DA, Irving MB, Posevitz V, Hebeisen M,
Posevitz-Fejfar A, Sarria J-CF, Gomez-Eerland R,
Thome M, Schumacher TNM, Romero P et al. (2010)
Evidence for a TCR affinity threshold delimiting
maximal CD8 T cell function. J Immunol 184, 4936–4946.
24 van der Merwe PA & Dushek O (2011) Mechanisms for
T cell receptor triggering. Nat Rev Immunol 11, 47–55.
25 Holland CJ, MacLachlan BJ, Bianchi V, Hesketh SJ,
Morgan R, Vickery O, Bulek AM, Fuller A, Godkin A,
Sewell AK et al. (2018) In silico and structural analyses
demonstrate that intrinsic protein motions guide T cell
receptor complementarity determining region loop
flexibility. Front Immunol 9, 674.
26 Reboul CF, Meyer GR, Porebski BT, Borg NA &
Buckle AM (2012) Epitope flexibility and dynamic
footprint revealed by molecular dynamics of a pMHC-
TCR complex. PLoS Comput Biol 8, e1002404.
27 Armstrong KM, Piepenbrink KH & Baker BM (2008)
Conformational changes and flexibility in T-cell
receptor recognition of peptide-MHC complexes.
Biochem J 415, 183–196.
28 Willcox BE, Gao GF, Wyer JR, Ladbury JE, Bell JI,
Jakobsen BK & van der Merwe PA (1999) TCR
binding to peptide-MHC stabilizes a flexible recognition
interface. Immunity 10, 357–365.
29 Krogsgaard M, Prado N, Adams EJ, He XL, Chow
DC, Wilson DB, Garcia KC & Davis MM (2003)
Evidence that structural rearrangements and/or
flexibility during TCR binding can contribute to T cell
activation. Mol Cell 12, 1367–1378.
30 Hawse WF, De S, Greenwood AI, Nicholson LK,
Zajicek J, Kovrigin EL, Kranz DM, Garcia KC &
Baker BM (2014) TCR scanning of peptide/MHC
through complementary matching of receptor and
ligand molecular flexibility. J Immunol 192, 2885–2891.
31 Scott DR, Borbulevych OY, Piepenbrink KH, Corcelli
SA & Baker BM (2011) Disparate degrees of
hypervariable loop flexibility control T-cell receptor
cross-reactivity, specificity, and binding mechanism. J
Mol Biol 414, 385–400.
32 Ayres CM, Scott DR, Corcelli SA & Baker BM (2016)
Differential utilization of binding loop flexibility in T
cell receptor ligand selection and cross-reactivity. Sci
Rep 6, 25070.
33 Scott DR, Vardeman CF, Corcelli SA & Baker BM
(2012) Limitations of time-resolved fluorescence
suggested by molecular simulations: assessing the
dynamics of T cell receptor binding loops. Biophys J
103, 2532–2540.
34 Knapp B, Dunbar J & Deane CM (2014) Large scale
characterization of the LC13 TCR and HLA-B8
structural landscape in reaction to 172 altered peptide
ligands: a molecular dynamics simulation study. PLoS
Comput Biol 10, e1003748.
35 Sewell AK (2012) Why must T cells be cross-reactive?
Nat Rev Immunol 12, 669–677.
36 Mason D (1998) A very high level of crossreactivity is
an essential feature of the T- cell receptor. Immunol
Today 19, 395–404.
37 Cole DK, van den Berg HA, Lloyd A, Crowther MD,
Beck K, Ekeruche-Makinde J, Miles JJ, Bulek AM, Dolton
G, Schauenburg AJ et al. (2017) Structural mechanism
underpinning cross-reactivity of a CD8 + T-cell clone that
recognizes a peptide derived from human telomerase
reverse transcriptase. J Biol Chem 292, 802–813.
38 Wooldridge L, Ekeruche-Makinde J, Van Den Berg
HA, Skowera A, Miles JJ, Tan MP, Dolton G, Clement
M, Llewellyn-Lacey S, Price DA et al. (2012) A single
autoimmune T cell receptor recognizes more than a
million different peptides. J Biol Chem 287, 1168–1177.
39 Birnbaum ME, Mendoza JL, Sethi DK, Dong S,
Glanville J, Dobbins J, Ozkan E, Davis MM,
Wucherpfennig KW & Garcia KC (2014)
Deconstructing the peptide-MHC specificity of T cell
recognition. Cell 157, 1073–1087.
40 Borbulevych OY, Piepenbrink KH & Baker BM (2011)
Conformational melding permits a conserved binding
geometry in TCR recognition of foreign and self
molecular mimics. J Immunol 186, 2950–2958.
41 Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce
MCJ, Kostenko L, Borg NA, Williamson NA, Beddoe
T, Purcell AW et al. (2007) A T cell receptor flattens a
bulged antigenic peptide presented by a major
histocompatibility complex class I molecule. Nat
Immunol 8, 268–276.
42 Insaidoo FK, Zajicek J & Baker BM (2009) A general
and efficient approach for NMR studies of peptide
15The FEBS Journal (2020) ª 2020 Cardiff University. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
J. R. Hopkins et al. Peptide cargo tunes HLA dynamics
dynamics in class I MHC peptide binding grooves.
Biochemistry 48, 9708–9710.
43 Ayres CM, Corcelli SA & Baker BM (2017) Peptide
and peptide-dependent motions in MHC proteins:
immunological implications and biophysical
underpinnings. Front Immunol 8, 935.
44 Madura F, Rizkallah PJ, Holland CJ, Fuller A, Bulek
A, Godkin AJ, Schauenburg AJ, Cole DK & Sewell
AK (2015) Structural basis for ineffective T-cell
responses to MHC anchor residue-improved
“heteroclitic” peptides. Eur J Immunol 45, 584–591.
45 Madura F, Rizkallah PJ, Legut M, Holland CJ, Fuller
A, Bulek A, Schauenburg AJ, Trimby A, Hopkins JR,
Wells SA et al. (2019) TCR-induced alteration of
primary MHC peptide anchor residue. Eur J Immunol
49, 1052–1066.
46 Borbulevych OY, Piepenbrink KH, Gloor BE, Scott
DR, Sommese RF, Cole DK, Sewell AK & Baker BM
(2009) T cell receptor cross-reactivity directed by
antigen-dependent tuning of peptide-MHC molecular
flexibility. Immunity 31, 885–896.
47 Reiser J-B, Darnault C, Gregoire C, Mosser T, Mazza
G, Kearney A, van der Merwe PA, Fontecilla-Camps
JC, Housset D & Malissen B (2003) CDR3 loop
flexibility contributes to the degeneracy of TCR
recognition. Nat Immunol 4, 241–247.
48 Auphan-Anezin N, Mazza C, Guimezanes A, Barrett-
Wilt GA, Montero-Julian F, Roussel A, Hunt DF,
Malissen B & Schmitt-Verhulst A-M (2006) Distinct
orientation of the alloreactive monoclonal CD8 T cell
activation program by three different peptide/MHC
complexes. Eur J Immunol 36, 1856–1866.
49 Hawse WF, Gloor BE, Ayres CM, Kho K, Nuter E &
Baker BM (2013) Peptide modulation of class I major
histocompatibility complex protein molecular flexibility
and the implications for immune recognition. J Biol
Chem 288, 24372–24381.
50 Ayres CM, Abualrous ET, Bailey A, Abraham C,
Hellman LM, Corcelli SA, Noe F, Elliott T & Baker
BM (2019) Dynamically driven allostery in MHC
proteins: peptide-dependent tuning of class I MHC
global flexibility. Front Immunol 10, 966.
51 Skowera A, Ladell K, McLaren JE, Dolton G,
Matthews KK, Gostick E, Kronenberg-Versteeg D,
Eichmann M, Knight RR, Heck S et al. (2015) b-cell-
specific CD8 T cell phenotype in type 1 diabetes reflects
chronic autoantigen exposure. Diabetes 64, 916–925.
52 Skowera A, Ellis RJ, Varela-Calvi~no R, Arif S, Huang
GC, Van-Krinks C, Zaremba A, Rackham C, Allen JS,
Tree TIM et al. (2008) CTLs are targeted to kill beta
cells in patients with type 1 diabetes through
recognition of a glucose-regulated preproinsulin
epitope. J Clin Invest 118, 3390–3402.
53 Knight RR, Kronenberg D, Zhao M, Huang GC,
Eichmann M, Bulek A, Wooldridge L, Cole DK, Sewell
AK, Peakman M & et al. (2013) Human b-cell killing
by autoreactive preproinsulin-specific CD8 T cells is
predominantly granule-mediated with the potency
dependent upon T-cell receptor avidity. Diabetes 62,
205–213.
54 Wiedersich J, K€ohler S, Skerra A & Friedrich J (2008)
Temperature and pressure dependence of protein
stability: the engineered fluorescein-binding lipocalin
FluA shows an elliptic phase diagram. Proc Natl Acad
Sci USA 105, 5756–5761.
55 Akasaka K (2006) Probing conformational fluctuation
of proteins by pressure perturbation. Chem Rev 106,
1814–1835.
56 Catici DAM, Amos HE, Yang Y, van den Elsen JMH
& Pudney CR (2016) The red edge excitation shift
phenomenon can be used to unmask protein structural
ensembles: implications for NEMO-ubiquitin
interactions. FEBS J 283, 2272–2284.
57 Fahnestock ML, Tamir I, Narhi L & Bjorkman PJ
(1992) Thermal stability comparison of purified empty
and peptide-filled forms of a class I MHC molecule.
Science 258, 1658–1662.
58 Hein Z, Uchtenhagen H, Abualrous ET, Saini SK, Janßen
L, Van Hateren A, Wiek C, Hanenberg H, Momburg F,
Achour A et al. (2014) Peptide-independent stabilization of
MHC class I molecules breaches cellular quality control. J
Cell Sci 127, 2885–2897.
59 Prabhu NV & Sharp KA (2005) Heat capacity in
proteins. Annu Rev Phys Chem 56, 521–548.
60 Vasilchuk D, Pandharipande PP, Suladze S, Sanchez-
Ruiz JM & Makhatadze GI (2014) Molecular
determinants of expansivity of native globular proteins:
a pressure perturbation calorimetry study. J Phys Chem
B 118, 6117–6122.
61 Royer CA (2005) Insights into the role of hydration in
protein structure and stability obtained through
hydrostatic pressure studies. Brazilian J Med Biol Res
38, 1167–1173.
62 Knapp B, Ospina L & Deane CM. (2018) Avoiding
false positive conclusions in molecular simulation: the
importance of replicas. J Chem Theory Comput 14,
6127–6138.
63 Thomas C & Tampe R (2017) Structure of the
TAPBPR-MHC I complex defines the mechanism of
peptide loading and editing. Science 358, 1060–1064.
64 Jiang J, Natarajan K, Boyd LF, Morozov GI, Mage
MG & Margulies DH (2017) Crystal structure of a
TAPBPR-MHC I complex reveals the mechanism of
peptide editing in antigen presentation. Science 358,
1064–1068.
65 Cole DK, Rizkallah PJ, Boulter JM, Sami M, Vuidepot
A, Glick M, Gao F, Bell JI, Jakobsen BK & Gao GF
(2007) Computational design and crystal structure of an
enhanced affinity mutant human CD8 alphaalpha
coreceptor. Proteins 67, 65–74.
16 The FEBS Journal (2020) ª 2020 Cardiff University. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
Peptide cargo tunes HLA dynamics J. R. Hopkins et al.
66 Laugel B, van den Berg HA, Gostick E, Cole DK,
Wooldridge L, Boulter J, Milicic A, Price DA & Sewell
AK (2007) Different T cell receptor affinity thresholds
and CD8 coreceptor dependence govern cytotoxic T
lymphocyte activation and tetramer binding properties.
J Biol Chem 282, 23799–23810.
67 Cole DK, Laugel B, Clement M, Price DA, Wooldridge
L & Sewell AK (2012) The molecular determinants of
CD8 co-receptor function. Immunology 137, 139–148.
68 Fisette O, Wingberm€uhle S & Sch€afer LV (2017) Partial
dissociation of truncated peptides influences the
structural dynamics of the MHCI binding groove. Front
Immunol 8, 408.
69 Insaidoo FK, Borbulevych OY, Hossain M,
Santhanagopolan SM, Baxter TK & Baker BM (2011)
Loss of T cell antigen recognition arising from changes
in peptide and major histocompatibility complex
protein flexibility. J Biol Chem 286, 40163–40173.
70 Abualrous ET, Saini SK, Ramnarayan VR, Ilca FT,
Zacharias M & Springer S (2015) The carboxy terminus of
the ligand peptide determines the stability of the MHC
class I molecule H-2Kb: a combined molecular dynamics
and experimental study. PLoS ONE 10, e0135421.
71 Ilca FT, Neerincx A, Hermann C, Marcu A, Stevanovic
S, Deane JE & Boyle LH (2018) TAPBPR mediates
peptide dissociation from MHC class I using a leucine
lever. eLife 7.
72 McShan AC, Natarajan K, Kumirov VK, Flores-Solis D,
Jiang J, Badst€ubner M, Toor JS, Bagshaw CR, Kovrigin
EL, Margulies DH & et al. (2018) Peptide exchange on
MHC-I by TAPBPR is driven by a negative allostery
release cycle. Nat Chem Biol 14, 811–820.
73 Girvan M & Newman MEJ (2002) Community
structure in social and biological networks. Proc Natl
Acad Sci USA 99, 7821–7826.
74 Valmori D, Fonteneau JF, Lizana CM, Gervois N,
Lienard D, Rimoldi D, Jongeneel V, Jotereau F,
Cerottini JC & Romero P (1998) Enhanced generation
of specific tumor-reactive CTL in vitro by selected
Melan-A/MART-1 immunodominant peptide
analogues. J Immunol 160, 1750–1758.
75 Cole DK, Edwards ESJ, Wynn KK, Clement M, Miles
JJ, Ladell K, Ekeruche J, Gostick E, Adams KJ,
Skowera A et al. (2010) Modification of MHC anchor
residues generates heteroclitic peptides that alter TCR
binding and T cell recognition. J Immunol 185, 2600–
2610.
76 Garboczi DN, Hung DT & Wiley DC (1992) HLA-A2-
peptide complexes: refolding and crystallization of
molecules expressed in Escherichia coli and complexed
with single antigenic peptides. Proc Natl Acad Sci USA
89, 3429–3433.
77 Cole DK, Rizkallah PJ, Gao F, Watson NI, Boulter
JM, Bell JI, Sami M, Gao GF & Jakobsen BK (2006)
Crystal structure of HLA-A*2402 complexed with a
telomerase peptide. Eur J Immunol 36, 170–179.
78 Webb B & Sali A (2014) Comparative protein structure
modeling using MODELLER. Curr Protoc
Bioinformatics 47, 5.6.1–5.6.32.
79 Søndergaard CR, Olsson MHM, Rostkowski M &
Jensen JH (2011) Improved treatment of ligands and
coupling effects in empirical calculation and
rationalization of pKa values. J Chem Theory Comput
7, 2284–2295.
80 Chen VB, Arendall WB, Headd JJ, Keedy DA,
Immormino RM, Kapral GJ, Murray LW, Richardson
JS & Richardson DC (2010) MolProbity : all-atom
structure validation for macromolecular
crystallography. Acta Crystallogr D Biol Crystallogr 66,
12–21.
81 Maier JA, Martinez C, Kasavajhala K, Wickstrom L,
Hauser KE & Simmerling C (2015) ff14SB: improving
the accuracy of protein side chain and backbone
parameters from ff99SB. J Chem Theory Comput 11,
3696–3713.
82 Jorgensen WL, Chandrasekhar J, Madura JD, Impey
RW & Klein ML (1983) Comparison of simple
potential functions for simulating liquid water. J Chem
Phys 79, 926–935.
83 Darden T, York D & Pedersen L (1993) Particle mesh
Ewald: An N ⋅log( N ) method for Ewald sums in large
systems. J Chem Phys 98, 10089–10092.
84 Roe DR & Cheatham TE (2013) PTRAJ and
CPPTRAJ: software for processing and analysis of
molecular dynamics trajectory data. J Chem Theory
Comput 9, 3084–3095.
85 Skjærven L, Yao X-Q, Scarabelli G & Grant BJ (2014)
Integrating protein structural dynamics and
evolutionary analysis with Bio3D. BMC Bioinformatics
15, 399.
86 Csardi G & Nepusz T (2006) The Igraph Software
package for complex network research. InterJournal
Complex Syst 1695, 1–9.
87 Yao X-Q, Malik RU, Griggs NW, Skjærven L, Traynor
JR, Sivaramakrishnan S & Grant BJ (2016) Dynamic
coupling and allosteric networks in the a subunit of
heterotrimeric G proteins. J Biol Chem 291, 4742–4753.
88 DeLano WL (2002) The PyMOL molecular graphics
system. Schr€odinger LLC wwwpymolorg Version 1,
http://www.pymol.org.
17The FEBS Journal (2020) ª 2020 Cardiff University. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
J. R. Hopkins et al. Peptide cargo tunes HLA dynamics
